You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Specific Immunotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

House Dust Mite Allergy Trial (Nigella Sativa Oil, Allergen Specific Immunotherapy, Standard pharmacotherapy)

Not yet recruiting
  • House Dust Mite Allergy
  • Nigella Sativa Oil
  • +2 more
  • (no location specified)
Jul 7, 2022

Peripheral Blood Neoantigen Specific T Cells Predict Efficacy of

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      Cancer hospital Fudan University
    Nov 30, 2022

    Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and Stroke (NINDS)

    Completed
    • Progressive Multifocal Leukoencephalopathy
    • PyVST
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

    Active, not recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • EGFR806-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Jan 18, 2023

    Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

    Recruiting
    • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
    • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
    • Shanghai, Shanghai, China
      Shanghai Renji Hospital
    Sep 12, 2023

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

    Recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • HER2-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Dec 14, 2022

    Allergic Rhinitis Trial in Beijing (AIT drops, Clarityne, Rhinocort and Emedastine Difumarate Eye Drops)

    Recruiting
    • Allergic Rhinitis
    • AIT drops
    • Clarityne, Rhinocort and Emedastine Difumarate Eye Drops
    • Beijing, China
    • +2 more
    May 21, 2022

    Recurrent Prostate Cancer Trial in New York (ADXS-504)

    Recruiting
    • Recurrent Prostate Cancer
    • New York, New York
      Columbia University Irving Medical Center
    Oct 10, 2021

    CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

    Recruiting
    • Central Nervous System Tumor
    • +10 more
    • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
    • Seattle, Washington
      Seattle Children's Hospital
    Dec 14, 2022

    Cytomegalovirus Infections, Hematopoietic Stem Cell Transplant, Opportunistic Infections Trial in Cleveland (CMV specific

    Recruiting
    • Cytomegalovirus Infections
    • +2 more
    • CMV specific adoptive t-cells
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jul 26, 2022

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Dendritic cell immunotherapy
    • +2 more
    • Ghent, Belgium
      Ghent University Hospital
    Dec 23, 2022

    Nonsmall Cell Lung Cancer, Performance Status Trial in Winston-Salem (Pembrolizumab, Carboplatin, Paclitaxel)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • Performance Status
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Dec 19, 2022

    Specific Immunotherapy With Pollinex Quattro on

    Completed
    • Rhinitis, Allergic
    • +4 more
    • Pollinex Quattro with tree- and grass pollen extracts and their mixtures
    • Cologne, Germany
      Outpatient Center Dr Stollewerk/Niebecker
    Feb 5, 2021

    Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria

    Suspended
    • Glioblastoma
    • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
    • +4 more
    • Durham, North Carolina
      Duke University Medical Center
    Aug 16, 2022

    Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

    Recruiting
    • Liver Cell Carcinoma
    • +7 more
    • CATCH T cells
    • +2 more
    • Houston, Texas
      Houston Methodist Hospital
    Dec 19, 2022

    Head and Neck Squamous Cell Cancer Trial in Philadelphia (INO-3112, CELLECTRA™-5P)

    Completed
    Has Results
    • Head and Neck Squamous Cell Cancer
    • INO-3112
    • CELLECTRA™-5P
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jan 4, 2021

    Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

    Terminated
    Has Results
    • Merkel Cell Polyomavirus Infection
    • Stage IV Merkel Cell Carcinoma AJCC v7
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Feb 25, 2022

    HIV Trial in Boston (Lymphocytes, Activated)

    Completed
    • HIV Infections
    • Lymphocytes, Activated
    • Boston, Massachusetts
      New England Med Ctr / Tufts Univ
    Oct 27, 2021

    Leukemia Trial in Seattle (Patient-derived CD22-specific CAR T-cells also expressing an EGFRt)

    Active, not recruiting
    • Leukemia
    • Patient-derived CD22-specific CAR T-cells also expressing an EGFRt
    • Seattle, Washington
      Seattle Children's Hospital
    Feb 15, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

    Completed
    Has Results
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 3, 2022

    Hepatocellular Carcinoma Trial in Houston (GLYCAR T cells, Cytoxan, Fludarabine)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • GLYCAR T cells
    • +2 more
    • Houston, Texas
      Houston Methodist Hospital
    Feb 13, 2022

    Epstein-Barr Virus Infections, Cytomegalovirus Infections, Adenovirus Trial in New York (Rapidly generated virus specific T

    Not yet recruiting
    • Epstein-Barr Virus Infections
    • +3 more
    • Rapidly generated virus specific T (R-MVST) cells
    • New York, New York
      Columbia University Irving Medical Center
    Feb 18, 2022

    Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

    Active, not recruiting
    • Metastatic Melanoma
    • Stage IV Cutaneous Melanoma AJCC v6 and v7
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 2, 2022

    Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma Trial in Seattle (Bomedemstat, Atezolizumab)

    Recruiting
    • Extensive Stage Lung Small Cell Carcinoma
    • Limited Stage Lung Small Cell Carcinoma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Mar 30, 2022